ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学内発行雑誌
  2. The Showa University journal of medical sciences
  3. Vol.32(2020)
  4. No.2

Simple Stratification of Hepatocellular Carcinoma Surveillance after Direct-acting Antiviral Therapy for Chronic Hepatitis C

https://showa.repo.nii.ac.jp/records/3460
https://showa.repo.nii.ac.jp/records/3460
f55225f1-26a3-4517-837b-1db31bc831b2
名前 / ファイル ライセンス アクション
S32_125.pdf S32_125.pdf (137.4 kB)
Item type 学内発行雑誌 / Departmental Bulletin Paper(1)
公開日 2020-08-19
タイトル
タイトル Simple Stratification of Hepatocellular Carcinoma Surveillance after Direct-acting Antiviral Therapy for Chronic Hepatitis C
言語
言語 eng
資源タイプ
資源タイプ departmental bulletin paper
著者 WANG, Tianpeng

× WANG, Tianpeng

WANG, Tianpeng

Search repository
SAKAKI, Masashi

× SAKAKI, Masashi

SAKAKI, Masashi

Search repository
ICHIKAWA, Yuki

× ICHIKAWA, Yuki

ICHIKAWA, Yuki

Search repository
OTOYAMA, Yumi

× OTOYAMA, Yumi

OTOYAMA, Yumi

Search repository
NAKAJIMA, Yoko

× NAKAJIMA, Yoko

NAKAJIMA, Yoko

Search repository
SUGIURA, Ikuya

× SUGIURA, Ikuya

SUGIURA, Ikuya

Search repository
ARAI, Jun

× ARAI, Jun

ARAI, Jun

Search repository
KAJIWARA, Atsushi

× KAJIWARA, Atsushi

KAJIWARA, Atsushi

Search repository
UOZUMI, Shojiro

× UOZUMI, Shojiro

UOZUMI, Shojiro

Search repository
SHIMOZUMA, Yuu

× SHIMOZUMA, Yuu

SHIMOZUMA, Yuu

Search repository
UCHIKOSHI, Manabu

× UCHIKOSHI, Manabu

UCHIKOSHI, Manabu

Search repository
YOSHIDA, Hitoshi

× YOSHIDA, Hitoshi

YOSHIDA, Hitoshi

Search repository
書誌情報 The Showa University journal of medical sciences

巻 32, 号 2, p. 125-133, 発行日 2020-07
抄録
内容記述タイプ Abstract
内容記述 Reports on surveillance systems useful for determining the risk of developing hepatocellular carcinoma (HCC) after direct-acting antiviral (DAA) treatment for hepatitis C have been published. Liver cirrhosis (LC) is a high-risk factor for HCC, but the evaluation frequency necessary for patients with chronic hepatitis (CH) remains unknown. Here, we aimed to identify how frequent CH patients should be evaluated for HCC, with particular emphasis on patients achieving a sustained virological response (SVR) with DAA treatment. Data were collected pre-treatment (Pre) and at the time of SVR for 141 patients with hepatitis C receiving DAA treatment. We defined LC by a platelet (PLT) count ≤10×104/µl, and CH was defined by a PLT count of >10×104/µl. The incidence of HCC in patients with CH after achieving SVR was retrospectively evaluated. In total, 128 patients (CH, n=102; LC, n=26) achieved SVR, and 13 developed HCC after SVR during the follow-up period (mean, 748 days). Although fibrosis-4 (FIB-4) index, the presence of α-fetoprotein, and prothrombin time were significant risk factors for HCC in patients with CH in the univariate analysis, only the Pre-FIB-4 index was an independent predictive factor for HCC development in the multivariate analysis (p=0.04). An FIB-4 index ≥3 was a significant risk factor for HCC (p=0.005). The cumulative risk for HCC at 1000 days was 2.6% and 24.2% in the FIB-4 index <3 and FIB-4 index ≥3 groups, respectively (p=0.004). Frequent HCC examination is recommended for FIB-4 index ≥3 CH patients who obtain SVR after DAA treatment.
DOI
関連識別子 10.15369/sujms.32.125
出版者
出版者 Showa University Society
ISSN
収録物識別子 2185-0968
出版タイプ
出版タイプ VoR
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 12:31:12.451742
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3